These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28266528)

  • 1. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry.
    Haimerl M; Verloh N; Zeman F; Fellner C; Nickel D; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    Sci Rep; 2017 Mar; 7():43347. PubMed ID: 28266528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Haimerl M; Schlabeck M; Verloh N; Zeman F; Fellner C; Nickel D; Barreiros AP; Loss M; Stroszczynski C; Wiggermann P
    Eur Radiol; 2016 Apr; 26(4):1125-33. PubMed ID: 26186960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.
    Yoneyama T; Fukukura Y; Kamimura K; Takumi K; Umanodan A; Ueno S; Nakajo M
    Eur Radiol; 2014 Apr; 24(4):857-65. PubMed ID: 24356768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.
    Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M
    J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with
    Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y
    Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time
    Haimerl M; Fuhrmann I; Poelsterl S; Fellner C; Nickel MD; Weigand K; Dahlke MH; Verloh N; Stroszczynski C; Wiggermann P
    Eur Radiol; 2018 Sep; 28(9):3591-3600. PubMed ID: 29532241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score.
    Haimerl M; Verloh N; Fellner C; Zeman F; Teufel A; Fichtner-Feigl S; Schreyer AG; Stroszczynski C; Wiggermann P
    Sci Rep; 2014 Jul; 4():5621. PubMed ID: 25001391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
    Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H
    Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary MRI: Signal intensity based assessment of liver function correlated to
    Haimerl M; Probst U; Poelsterl S; Beyer L; Fellner C; Selgrad M; Hornung M; Stroszczynski C; Wiggermann P
    Sci Rep; 2018 Jun; 8(1):9078. PubMed ID: 29899400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help.
    Xu J; Wang X; Jin ZY; Wang Q; You Y; Wang ST; Qian TY; Xue HD
    Chin Med Sci J; 2021 Jun; 36(2):110-119. PubMed ID: 34231459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging-based evaluation of liver function: comparison of ⁹⁹mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI.
    Geisel D; Lüdemann L; Fröling V; Malinowski M; Stockmann M; Baron A; Gebauer B; Seehofer D; Prasad V; Denecke T
    Eur Radiol; 2015 May; 25(5):1384-91. PubMed ID: 25447973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure.
    Donadon M; Lanza E; Branciforte B; Muglia R; Lisi C; Pedicini V; Poretti D; Famularo S; Balzarini L; Torzilli G
    Surgery; 2020 Sep; 168(3):419-425. PubMed ID: 32600880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.
    Dahlqvist Leinhard O; Dahlström N; Kihlberg J; Sandström P; Brismar TB; Smedby O; Lundberg P
    Eur Radiol; 2012 Mar; 22(3):642-53. PubMed ID: 21984449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
    Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
    Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.